I

n a move that elicited rare agreement among groups representing consumers and the pharmaceutical industry, the European Commission proposed various steps to accelerate the approval of drugs and devices by European Union member states.

Although the proposal follows more than 20 years of voluntary cooperation, the commission is hoping to memorialize the effort in order to streamline procedures that so medical products can reach patients faster and companies can more easily seek regulatory approvals.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.